Françoise Meunier: MEP Kateřina Konečná reiterated her support for cancer survivor’s rights need to be guaranteed through legislative measures at the European level
Françoise Meunier, Founder of the European Initiative on Ending Discrimination Against Cancer Survivors, shared a post on LinkedIn:
‘”We must not be ruled by voluntary codes of conduct. Only regulations will ensure the rights [cancer survivors] are entitled to.’
During the High-Level Conference, MEP Kateřina Konečná reiterated her support for the argument that I have been supporting: that cancer survivors’ rights need to be guaranteed through legislative measures at the European level.
This is the only way to ensure implementation and harmonisation so that, no matter where they live, European cancer survivors can access financial services without discrimination.”
Proceed to video.
Source: Françoise Meunier/LinkedIn
Françoise Meunier dedicated her professional life to improving the survival and QoL of cancer patients. Prof. Meunier served as Director-General of the European organization for Research and Treatment of Cancer (1991-2015), where she remained active until 2018 as Director of Special Projects, being the driving force behind cancer survivorship activities.
Since 2014, she has been pursuing activities on the Right to be Forgotten for cancer survivors, advocating for the creation of a harmonised legal framework to tackle discrimination against cancer survivors. Prior to joining the EORTC, Françoise Meunier was Head of Infectious Diseases Department at Institute Jules Bordet.
Prof. Meunier was awarded the Belgian Laureate Prix Femmes d’Europe 2004-2005, conferred the title of Baroness by His Majesty, King Albert II of Belgium in 2007, received the Pezcoller Foundation award in 2009, became a Fellow of the European Academy of Cancer Sciences in 2011, joined the Scientific Committee of the Innovative Medicine Initiative of the European Union in 2012, received the ECCO Life time achievement award in 2013, awarded a Ben de Pauw Medal for her dedication to Medical Mycology in 2013, appointed council member of the Federation of European Academies of Medicine in 2014, appointed Chair of Accreditation Council of Oncology in Europe and Member of Alliance for Biomedical Research in Europe in 2015, and has been a member of the Belgian Royal Academy of Medicine since 2006.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023